Haleon earnings were $2.3B for the trailing 12 months ending Dec 31, 2025, with 27.3% growth year over year. The latest HLN earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, HLN reported annual earnings of $2.3B, with 25% growth.
HLN past earnings growth
How has HLN's earnings growth performed historically?
On HLN's earnings call on Invalid Date, Haleon (NYSE: HLN) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total HLN earnings for the quarter were N/A. In the same quarter last year, Haleon's earnings per share (EPS) was N/A.
As of the last Haleon earnings report, Haleon is currently profitable. Haleon's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $2.25 billion, a 24.98% increase year over year.
What was HLN's earnings growth in the past year?
As of Haleon's earnings date in Invalid Date, Haleon's earnings has grown 27.34% year over year. This is 5.32 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 32.67%. HLN earnings in the past year totalled $2.25 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.